Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Xeris Pharmaceuticals Inc (NQ: XERS )

5.370 USD -0.370 (-6.45%)
Official Closing Price Updated: 7:58 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Xeris Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Xeris Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 243%
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke® in Israel and the Palestinian Authority
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
Interesting XERS Call Options For February 2021
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XERS... 
Tags Stocks
From Market News Video
72 Biggest Movers From Friday
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ... 
Tags INSG BRN SGMO
From Benzinga
4 Penny Stocks To Watch Before 2021 & 2 Jumped Over 200% In Q4
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
60 Stocks Moving In Friday's Mid-Day Session
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) shares jumped 111.5% to $23.48 on a merger deal with EV charging company ... 
Tags AYTU FIII PBLA
From Benzinga
Thinking about buying stock in Nantkwest, Ampio Pharmaceuticals, Arbutus Biopharma, Xeris Pharmaceuticals, or iBio Inc?
InvestorsObserver issues critical PriceWatch Alerts for NK, AMPE, ABUS, XERS, and IBIO. 
From PR Newswire
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DVAX ADPT CORT
From Benzinga
50 Stocks Moving in Friday's Pre-Market Session
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) rose 173.2% to $30.35 in pre-market trading on a merger deal with EV ... 
Tags DIS SNOA Trading Ideas
From Benzinga
Xeris Pharmaceuticals Receives Positive CHMP Opinion for Ogluo™, Its Ready-To-Use (RTU) Glucagon for Injection, for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Ye
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and... 
From Business Wire News Releases
41 Stocks Moving in Wednesday's Pre-Market Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 65.1% to $0.6770 in pre-market trading. Tredegar Corporation (NYSE: TG) rose 35.2% to ... 
Tags EYES WKHS Trading Ideas
From Benzinga
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
First Week of July 2021 Options Trading For Xeris Pharmaceuticals (XERS)
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
VTWV's Holdings Could Mean 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Tuesday Option Activity: XERS, PS, FICO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Xeris Pharmaceuticals Inc (XERS), where a total of 10,908 contracts have traded so far,... 
Tags Stocks
From Market News Video
Xeris Pharmaceuticals: Q3 Earnings Insights
Shares of Xeris Pharmaceuticals (NASDAQ:XERS) moved higher by 4.6% in pre-market trading after the company reported Q3 ... 
Tags Earnings Benzinga XERS
From Benzinga
Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and... 
From Business Wire News Releases
Earnings Scheduled For November 9, 2020
Companies Reporting Before The Bell • General Finance (NASDAQ:GFN) is projected to report quarterly earnings at $0.03 ... 
Tags WTRH TCO VRS
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags LPTX DRRX MYGN
From Benzinga
Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CRSP IMMU CDAK
From Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
Gainers Astrotech Corporation (NASDAQ: ASTC) rose 217.5% to $5.27 in pre-market trading after the company announced partnership ... 
Tags Trading Ideas HTZ NNDM
From Benzinga
16 Stocks Moving In Tuesday's After-Hours Session
Gainers Astrotech (NASDAQ: ASTC) shares are trading higher after the company announced it partnered with TheCleveland Clinic ... 
Tags USNA FB After/Hours Center
From Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Xeris Pharmaceuticals (NASDAQ:XERS) stock moved upwards by 10.47% to $5.8 during Tuesday's after-market session. Xeris ... 
Tags NEPT SOS General
From Benzinga
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
First Week of XERS December 18th Options Trading
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.